EM-T3Pharmacoepidemiology and Drug Safety2016-06-01第 25 卷第 6 期，745-746通讯与评论
Response to letter to the editor regarding Alqahtani et al. Article on priority review drugs approved by the FDA and the EMA: time for international regulatory harmonization of pharmaceuticals?
